Pfizer’s buyout bid for Metsera was deemed inferior to the latest bid from Novo Nordisk, putting the original agreement in ...

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

The number of medications in development to treat obesity continues to grow, and the drugs can offer health benefits for ...

The United States has said it will speed up approval for some generic drugs. The development comes weeks after it was ...

Blackstone Life Sciences agreed to give Merck $700 million to support its development of an investigational cancer drug called sacituzumab tirumotecan in exchange for low-to-mid-single-digit royalties ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...

India's top drug regulator cited insufficient evidence of efficacy in the two studies conducted by Serum Institute and ICMR.

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

NetTargets employs an AI system that combines multi-omics data with neural network modelling for drug discovery.

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...

Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...